Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review
The antimicrobial drugs currently used for the management of tuberculosis (TB) exhibit poor bioavailability that necessitates prolonged treatment regimens and high dosing frequency to achieve optimal therapeutic outcomes. In addition, these agents cause severe adverse effects, as well as having detr...
Shranjeno v:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2021-11-01
|
| Serija: | Pharmaceutics |
| Teme: | |
| Online dostop: | https://www.mdpi.com/1999-4923/13/12/2041 |
| Oznake: |
Brez oznak, prvi označite!
|